Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 220 participants.
Also called NCT06917664
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 220 participants
- Sponsor
- Registry
-
NCT06917664
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06917664. Randomized; single masking; primary purpose treatment. Start 2025-06-05 (actual); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease
- Condition
- Coronary Artery Disease
- Condition
- Ischemic Mitral Regurgitation
- Condition
- Angiotensin Receptor/Neprilysin Inhibitor
- Intervention (Drug)
- sacubitril/valsartan
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Collaborator
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Collaborator
- Chinese Academy of Medical Sciences
Record details
- Record id
cardio:ct-nct06917664- Content hash
6fc329e24954951a45ac025656bbb76d39dd6851aa81b935fd7ffdd34cbe331e